• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Real-world evidence in antiretroviral therapy: drug safety data.抗逆转录病毒疗法的真实世界证据：药物安全性数据。
Braz J Infect Dis. 2020 May-Jun;24(3):271-272. doi: 10.1016/j.bjid.2020.04.013. Epub 2020 May 15.
2
High incidence of adverse reactions to initial antiretroviral therapy in Brazil.巴西初始抗逆转录病毒治疗不良反应的高发生率。
Braz J Med Biol Res. 2006 Apr;39(4):495-505. doi: 10.1590/s0100-879x2006000400010. Epub 2006 Apr 3.
3
Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.评论：富马酸替诺福韦二吡呋酯在儿科抗逆转录病毒治疗中的地位。
Pediatr Infect Dis J. 2015 Apr;34(4):406-8. doi: 10.1097/INF.0000000000000650.
4
Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus.高效抗逆转录病毒疗法在初治HIV患者中的安全性和有效性：白俄罗斯一项队列事件监测研究的初步结果
Drug Saf. 2015 Apr;38(4):365-72. doi: 10.1007/s40264-015-0279-7.
5
Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda.乌干达两家公共卫生机构中接受高效抗逆转录病毒治疗患者的疑似肾毒性靶向自发报告。
Drug Saf. 2015 Apr;38(4):395-408. doi: 10.1007/s40264-015-0277-9.
6
Adverse Drug Reactions to Antiretroviral Therapy in Children with HIV-An Important Factor in Adherence to Antiretroviral Therapy.HIV感染儿童抗逆转录病毒治疗的药物不良反应——影响抗逆转录病毒治疗依从性的重要因素
Indian J Pediatr. 2023 Jan;90(1):1-2. doi: 10.1007/s12098-022-04333-7. Epub 2022 Sep 19.
7
A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe.津巴布韦抗逆转录病毒和抗结核治疗患者药物不良反应谱比较。
Clin Drug Investig. 2018 Jan;38(1):9-17. doi: 10.1007/s40261-017-0579-z.
8
Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?除脂肪代谢障碍外：毒性问题会否超过高效抗逆转录病毒治疗的益处？
J HIV Ther. 2003 May;8(2):27-8.
9
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.英国HIV协会（BHIVA）关于使用抗逆转录病毒疗法治疗HIV感染成人的指南。
HIV Med. 2001 Oct;2(4):276-313. doi: 10.1046/j.1464-2662.2001.00083.x.
10
Self-reported adverse reactions among patients initiating antiretroviral therapy in Brazil.巴西开始接受抗逆转录病毒治疗的患者中自我报告的不良反应。
Braz J Infect Dis. 2007 Feb;11(1):20-6. doi: 10.1590/s1413-86702007000100007.

本文引用的文献

1
Factors associated to modification of first-line antiretroviral therapy due to adverse events in people living with HIV/AIDS.与 HIV/AIDS 患者因不良反应而修改一线抗逆转录病毒治疗相关的因素。
Braz J Infect Dis. 2020 Jan-Feb;24(1):65-72. doi: 10.1016/j.bjid.2019.11.002. Epub 2019 Dec 10.
2
Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age.按年龄分层的第一年治疗期间因毒性而改变或停止首次联合抗逆转录病毒治疗方案的发生率。
Braz J Infect Dis. 2014 Jan-Feb;18(1):34-41. doi: 10.1016/j.bjid.2013.04.005. Epub 2013 Sep 9.
3
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study.预测因药物相关不良反应而中断一线抗逆转录病毒治疗的因素：一项回顾性队列研究。
BMC Infect Dis. 2012 Nov 12;12:296. doi: 10.1186/1471-2334-12-296.
4
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.住院患者药物不良反应的发生率：前瞻性研究的荟萃分析
JAMA. 1998 Apr 15;279(15):1200-5. doi: 10.1001/jama.279.15.1200.

Real-world evidence in antiretroviral therapy: drug safety data.

作者信息

Silva Ana-Marta, Pereira Marta, Dias Cláudia Camila, Ventura Ângela, Sousa-Pinto Bernardo

机构信息

University of Porto, Faculty of Medicine, Northern Pharmacovigilance Centre (UFPorto), Porto, Portugal; University of Porto, Faculty of Medicine, Health Information and Decision (MEDCIDS), Porto, Portugal; University of Porto, Faculty of Medicine, Center for Health Technology and Service Research (CINTESIS), Porto, Portugal.

Pharmacy of Centro Hospitalar Universitário do Porto (CHUP), Porto, Portugal.

出版信息

Braz J Infect Dis. 2020 May-Jun;24(3):271-272. doi: 10.1016/j.bjid.2020.04.013. Epub 2020 May 15.

DOI:10.1016/j.bjid.2020.04.013
PMID:32417161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9392085/
Abstract
摘要